Focal Medical, a startup with roots at UNC-Chapel Hill, is finalizing plans with the FDA to enroll pancreatic cancer patients in its first clinical trial. The company’s implantable technology uses an electrical field to deliver drugs in higher concentrations to … Read more

UNC-affiliated startup Triangle Biotechnology’s nanoparticle technology amplifies the power of sound to give scientists rapid, higher-quality sample analysis capabilities—and clinicians hope for pinpointing the right treatments for patients faster and earlier.